• About
    • Our Company
    • Board of Directors
    • Leadership Team
    • Research Partners
    • Corporate Social Responsibility
    • Corporate Governance
  • Product Pipeline
    • Pipeline
    • Oncology (tigilanol tiglate)
      • Human
      • Veterinary
      • Publications
    • Wound Healing (EBC-1013)
    • Antibiotics
    • EcoLogic™
  • Investors
    • Investor information
    • Announcements
    • Media archive
    • Buy & sell shares
    • Shareholder log in
  • Partners
  • Contact

Cornerstone Investor Joins QBiotics

 
Media Release:
QBiotics welcomes TDM Growth Partners as cornerstone investor in a capital raise to accelerate drug development timelines

Announcement:
QBiotics announces plan to raise up to AU$75 million

 

 

  • Investors
  • FAQs
  • Media
  • Careers
  • Register for updates
  • Contact
  • Privacy policy
  • Terms of use

© QBiotics. All Rights Reserved.

Existing QBiotics Shareholder

For information about our privacy practices, please view our privacy policy. You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By clicking above to register, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.